Exclusive: Citius Pharmaceuticals Exec Chairman On Product Pipeline, Potential $1B TAM
Citius Pharmaceuticals Inc. (NASDAQ: CTXR) Executive Chairman Leonard Mazur told Benzinga CEO Jason Raznick Thursday that he's invested $26.5 million of his own money in the specialty pharmaceutical company.
